Most viruses of clinical relevance encode antagonists that interfere with the type I interferon (IFN) pathway thus promoting the establishment of the infection and pathology. The mechanisms involved in initiating the antiviral immune response in the presence of antagonists of the type I IFN pathway have not been identified. These mechanisms may represent novel targets to minimize pathology and/or may explain different clinical outcomes to common viral pathogens. Our group established that special defective forms of viral genomes (DVGs), which were until recently considered an epiphenomenon of in vitro virus replication, are potent danger signals that trigger the host response, even in the presence of virus-encoded antagonists. Moreover, we demonstrated that natural accumulation of DVGs in the lung during infection with the mouse respiratory pathogen Sendai virus (SeV) or with mouse-adapted influenza A virus (IAV) correlated with the onset of the antiviral response, and that production of the primary antiviral cytokine IFN beta was limited to the DVG-positive lung cellular fraction. Importantly, analysis of respiratory secretions from children infected with the SeV-related human respiratory syncytial virus (RSV) demonstrated that detection of DVGs is also associated with enhanced expression of transcripts for type I IFNs in humans. Notably, DVGs have been identified in the serum of patients infected with a variety of viruses and our data are the first demonstration that DVGs generated during an acute infection promote the onset of the immune response in vivo. We thus hypothesize that DVGs are essential for the induction of the antiviral response in infections with viruses that block the type I IFN pathway and that their presence determines the clinical outcome of the infection. The goals of this renewal application are (i) to identify unique molecular mechanisms governing the strong immunostimulatory ability of DVGs, (ii) to determine how do DVGs initiate the immune response in vivo, and (iii) to evaluate the role of RSV DVGs in the virus pathogenesis in the human lung. Overall, these studies will advance our understanding of the mechanisms involved in the onset of the innate immune response to virus infection and may have a significant impact on the development of novel antiviral treatments and prognostic tools.

Public Health Relevance

Identification of host and virus factors promoting efficient clearance of the viral infection and diminishing pathology should accelerate the design of novel antiviral treatments and prognostic tools. This application is centered on the study of defective viral genomes as key determinants of the host immune response against respiratory viruses.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
2R01AI083284-06
Application #
8757286
Study Section
Virology - B Study Section (VIRB)
Program Officer
Leitner, Wolfgang W
Project Start
2009-07-01
Project End
2018-06-30
Budget Start
2014-07-15
Budget End
2015-06-30
Support Year
6
Fiscal Year
2014
Total Cost
Indirect Cost
Name
University of Pennsylvania
Department
Pathology
Type
Schools of Veterinary Medicine
DUNS #
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Xue, Jia; Chambers, Benjamin S; Hensley, Scott E et al. (2016) Propagation and Characterization of Influenza Virus Stocks That Lack High Levels of Defective Viral Genomes and Hemagglutinin Mutations. Front Microbiol 7:326
Penkala, Ian; Wang, Jianle; Syrett, Camille M et al. (2016) lncRHOXF1, a Long Noncoding RNA from the X Chromosome That Suppresses Viral Response Genes during Development of the Early Human Placenta. Mol Cell Biol 36:1764-75
Benitez, Asiel A; Panis, Maryline; Xue, Jia et al. (2015) In Vivo RNAi Screening Identifies MDA5 as a Significant Contributor to the Cellular Defense against Influenza A Virus. Cell Rep 11:1714-26
Xu, Jie; Mercado-López, Xiomara; Grier, Jennifer T et al. (2015) Identification of a Natural Viral RNA Motif That Optimizes Sensing of Viral RNA by RIG-I. MBio 6:e01265-15
Sun, Yan; Jain, Deepika; Koziol-White, Cynthia J et al. (2015) Immunostimulatory Defective Viral Genomes from Respiratory Syncytial Virus Promote a Strong Innate Antiviral Response during Infection in Mice and Humans. PLoS Pathog 11:e1005122
López, Carolina B (2014) Defective viral genomes: critical danger signals of viral infections. J Virol 88:8720-3
Kim, Won-Keun; Jain, Deepika; Sánchez, Melissa D et al. (2014) Deficiency of melanoma differentiation-associated protein 5 results in exacerbated chronic postviral lung inflammation. Am J Respir Crit Care Med 189:437-48
Mercado-López, Xiomara; Cotter, Christopher R; Kim, Won-Keun et al. (2013) Highly immunostimulatory RNA derived from a Sendai virus defective viral genome. Vaccine 31:5713-21
Tapia, Karla; Kim, Won-Keun; Sun, Yan et al. (2013) Defective viral genomes arising in vivo provide critical danger signals for the triggering of lung antiviral immunity. PLoS Pathog 9:e1003703
Hermesh, Tamar; Moran, Thomas M; Jain, Deepika et al. (2012) Granulocyte colony-stimulating factor protects mice during respiratory virus infections. PLoS One 7:e37334

Showing the most recent 10 out of 15 publications